Phase 3 randomised trial of eltrombopag versus standard first-line pharmacological management for newly diagnosed immune thrombocytopaenia (ITP) in children: study protocol

Shimano, K. A., Grace, R. F., Despotovic, J. M., Neufeld, E. J., Klaassen, R. J., Bennett, C. M., Ma, C., London, W. B., & Neunert, C. (2021). Phase 3 randomised trial of eltrombopag versus standard first-line pharmacological management for newly diagnosed immune thrombocytopaenia (ITP) in children: study protocol. BMJ Open, 11(8), e044885. https://doi.org/10.1136/bmjopen-2020-044885

Authors:

Kristin A Shimano

Rachael F Grace

Jenny M Despotovic

Ellis J Neufeld

Robert J Klaassen

Carolyn M Bennett

Clement Ma

Wendy B London

Cindy Neunert

Affiliated Authors:

Cindy Neunert